Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition

BACKGROUND: Thrombotic microangiopathy (TMA) is a potentially organ and life-threatening condition affecting patients with multiple myeloma (MM). Cases of proteasome inhibitor-induced TMA and specifically carfilzomib-induced TMA have been rarely reported and standards for diagnostic workup and treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Catanese, Lorenzo, Link, Katharina, Rupprecht, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278274/
https://www.ncbi.nlm.nih.gov/pubmed/37337151
http://dx.doi.org/10.1186/s12882-023-03228-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278274/
https://www.ncbi.nlm.nih.gov/pubmed/37337151
http://dx.doi.org/10.1186/s12882-023-03228-9

Ejemplares similares